On May 05, 2026, XRAY reported earnings of 0.27 USD per share (EPS) for Q1 26, missing the estimate of 0.28 USD, resulting in a -5.26% surprise. Revenue reached 880.00 million, compared to an expected 857.72 million, with a 2.60% difference. The market reacted with a -2.02% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 14 analysts forecast an EPS of 0.36 USD, with revenue projected to reach 907.13 million USD, implying an increase of 33.33% EPS, and increase of 3.08% in Revenue from the last quarter.